MX345413B - Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana. - Google Patents

Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.

Info

Publication number
MX345413B
MX345413B MX2013009087A MX2013009087A MX345413B MX 345413 B MX345413 B MX 345413B MX 2013009087 A MX2013009087 A MX 2013009087A MX 2013009087 A MX2013009087 A MX 2013009087A MX 345413 B MX345413 B MX 345413B
Authority
MX
Mexico
Prior art keywords
bifidobacteria
growth
modulation
combination
human milk
Prior art date
Application number
MX2013009087A
Other languages
English (en)
Other versions
MX2013009087A (es
Inventor
Curtis Frantz David
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45809349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX345413(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013009087A publication Critical patent/MX2013009087A/es
Publication of MX345413B publication Critical patent/MX345413B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una formulación prebiótica para la administración oral a un ser humano, caracterizada porque comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, donde la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa, y en donde la 2´-fucosilactosa, 3´sialilactosa y 6´-sialilactosa comprenden de 1.6-6.0% del peso seco de la formulación.
MX2013009087A 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana. MX345413B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161441451P 2011-02-10 2011-02-10
PCT/IB2012/050511 WO2012107865A2 (en) 2011-02-10 2012-02-03 Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Publications (2)

Publication Number Publication Date
MX2013009087A MX2013009087A (es) 2013-09-13
MX345413B true MX345413B (es) 2017-01-27

Family

ID=45809349

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013009087A MX345413B (es) 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.
MX2014008513A MX362129B (es) 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2014008513A MX362129B (es) 2011-02-10 2012-02-03 Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.

Country Status (18)

Country Link
US (3) US20140371173A1 (es)
EP (2) EP2792252B1 (es)
CN (2) CN103347405A (es)
AU (1) AU2012215042B2 (es)
BR (1) BR112013020108A2 (es)
CA (1) CA2825697A1 (es)
CL (1) CL2013002210A1 (es)
ES (2) ES2527200T5 (es)
IL (1) IL227487A (es)
MX (2) MX345413B (es)
MY (1) MY161034A (es)
PL (1) PL2672844T3 (es)
PT (1) PT2672844E (es)
RU (1) RU2586928C2 (es)
SG (1) SG192095A1 (es)
TW (1) TW201244640A (es)
WO (1) WO2012107865A2 (es)
ZA (1) ZA201306751B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012215042B2 (en) 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
EP3366143A1 (en) 2011-06-20 2018-08-29 H.J. Heinz Company Brands LLC Probiotic compositions and methods
EP2836218A4 (en) * 2012-04-13 2015-10-21 Trustees Boston College PROBIOTIC COMPOSITIONS AND METHODS OF USE
DK2708145T3 (en) 2012-09-14 2016-07-18 Abbott Lab Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals
EP3129030A1 (en) 2014-04-08 2017-02-15 Abbott Laboratories Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
DK3209308T3 (da) * 2014-10-24 2022-10-03 Evolve Biosystems Inc Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
EP3223826A1 (en) * 2014-11-26 2017-10-04 Abbott Laboratories Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic
RU2706963C2 (ru) * 2014-11-26 2019-11-21 Абботт Лаборэтриз Молочная смесь, содержащая олигосахариды грудного молока, полиненасыщенные жирные кислоты, нуклеотиды и лютеин
WO2016091265A1 (en) * 2014-12-08 2016-06-16 Glycom A/S Synthetic composition for treating metabolic disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US20180078572A1 (en) * 2015-03-05 2018-03-22 Nestec S.A. Compositions for use in improving stool consistency or frequency in infants or young children
WO2017071715A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
EP3368047B1 (en) * 2015-10-28 2023-04-26 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US11957148B2 (en) * 2015-12-15 2024-04-16 Societe Des Produits Nestle S.A. Mixture of human milk oligosaccharides(HMOs)
MX2019000881A (es) * 2016-07-28 2019-07-01 Fonterra Cooperative Group Ltd Producto lacteo y proceso.
EP3641566A1 (en) * 2017-06-21 2020-04-29 Abbott Laboratories Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
US20220241354A1 (en) * 2019-06-05 2022-08-04 Morinaga Milk Industry Co., Ltd. Composition
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260280A (en) 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
CA2400737C (en) * 2000-02-17 2010-12-14 Jeffrey L. Wilson Nutritional formulation containing prebiotic substances
JP2003522577A (ja) * 2000-02-18 2003-07-29 アーゴス インク 細胞サンプルおよび組織サンプルの緑色〜紫外スペクトルの多変量分析
US6913778B2 (en) 2001-12-21 2005-07-05 Wyeth Infant formula compositions comprising increased amounts of alpha-lactalbumin
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US8394370B2 (en) * 2003-06-23 2013-03-12 Nestec S.A. Nutritional formula for optimal gut barrier function
JP5236189B2 (ja) 2003-12-05 2013-07-17 チルドレンズ ホスピタル メディカル センター オリゴ糖組成物および感染症の治療における該組成物の使用
CN101299924A (zh) 2005-11-04 2008-11-05 阿拉乳品公司 一种源于富含天然存在的唾液酰乳糖的乳制品的浓缩物及其制备方法
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) † 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
NL2001377C2 (nl) † 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.
US20120121562A1 (en) * 2009-07-31 2012-05-17 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
NL2004200C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
CN102858191A (zh) * 2010-04-27 2013-01-02 N.V.努特里奇亚 6’-唾液酸化乳糖在婴儿和幼儿营养物中的用途
CN103763940B (zh) * 2010-12-31 2015-10-14 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
AU2012215042B2 (en) 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Also Published As

Publication number Publication date
EP2672844A2 (en) 2013-12-18
EP2672844B1 (en) 2014-11-19
ES2692533T3 (es) 2018-12-04
US20140371173A1 (en) 2014-12-18
CN104126749A (zh) 2014-11-05
WO2012107865A2 (en) 2012-08-16
IL227487A (en) 2015-10-29
ES2527200T3 (es) 2015-01-21
CL2013002210A1 (es) 2014-01-10
WO2012107865A3 (en) 2012-11-01
US20120208782A1 (en) 2012-08-16
EP2792252A3 (en) 2015-03-25
CA2825697A1 (en) 2012-08-16
ZA201306751B (en) 2015-05-27
US20150141367A1 (en) 2015-05-21
RU2013141449A (ru) 2015-03-20
BR112013020108A2 (pt) 2017-06-13
PT2672844E (pt) 2015-02-04
MY161034A (en) 2017-04-14
IL227487A0 (en) 2013-09-30
EP2792252A2 (en) 2014-10-22
EP2672844B2 (en) 2022-10-05
PL2672844T3 (pl) 2015-04-30
RU2586928C2 (ru) 2016-06-10
EP2792252B1 (en) 2018-09-12
SG192095A1 (en) 2013-08-30
CN103347405A (zh) 2013-10-09
ES2527200T5 (es) 2022-12-29
TW201244640A (en) 2012-11-16
MX2013009087A (es) 2013-09-13
MX362129B (es) 2019-01-07
AU2012215042B2 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
MY161034A (en) Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
EP3904502A3 (en) Compositions and methods
NZ613180A (en) Methods of using human milk oligosaccharides for improving airway respiratory health
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
MX2014004548A (es) Metodos para tratar pacientes pediatricos usando dexmedetomidina.
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
NZ612105A (en) Human milk oligosaccharides for modulating inflammation
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
NZ612386A (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
MY173215A (en) Acetylcysteine compositions and methods of use thereof
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
NZ701607A (en) Therapeutic use of chardonnay seed products
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2014110353A9 (en) Notch ligand bound biocompatible substrates and their use in bone formation
GB201200858D0 (en) Prebiotic powder composition and uses thereof
WO2011044523A3 (en) Compositions and methods for treating obesity
EA201390417A1 (ru) Антидиабетические твердые фармацевтические композиции
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
PH12014501822A1 (en) Oral formulation comprising lansoprazole and the preparation method thereof
WO2011028797A3 (en) Treatment of glaucoma and other retinopathies with gangliosides
JO2861B1 (en) Use of 4-methoxy-propyl annular -N- - (3.5-dichloro-1-oxoperidine-4 yl) -5 (methoxy) pyridine-2-carboxamide in the treatment of brain tumors)
梁凌智 Preliminary study of smile correlative esthetic factors
UA74544U (ru) Способ лечения и профилактики хронического генерализованного пародонтита

Legal Events

Date Code Title Description
FG Grant or registration